Evidence map›Paper›PMID 30488351›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2019

The amendatory effect of hesperidin and thymol in allergic rhinitis: an ovalbumin-induced rat model.

Korhan Kilic, Muhammed Sedat Sakat, Serkan Yildirim, Fatih Mehmet Kandemir, Mustafa Sitki Gozeler, Muhammed Bahaeddin Dortbudak, Sefa Kucukler

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. The protective effect of Naringenin against ovalbumin-induced allergic rhinitis in rats.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2021
    Article
  17. Article
  18. Article
  19. Extract ofMolecules (Basel, Switzerland) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Korhan KilicDepartment of Otorhinolaryngology, Ataturk University, Faculty of Medicine, 25240, Erzurum, Turkey. korhankilic@gmail.com.ORCID http://orcid.org/0000-0001-6048-034X
Muhammed Sedat SakatDepartment of Otorhinolaryngology, Ataturk University, Faculty of Medicine, 25240, Erzurum, Turkey.
Serkan YildirimDepartment of Pathology, Ataturk University, Faculty of Veterinary, Erzurum, Turkey.
Fatih Mehmet KandemirDepartment of Biochemistry, Ataturk University, Faculty of Veterinary, Erzurum, Turkey.
Mustafa Sitki GozelerDepartment of Otorhinolaryngology, Ataturk University, Faculty of Medicine, 25240, Erzurum, Turkey.
Muhammed Bahaeddin DortbudakDepartment of Pathology, Ataturk University, Faculty of Veterinary, Erzurum, Turkey.
Sefa KucuklerDepartment of Biochemistry, Ataturk University, Faculty of Veterinary, Erzurum, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeAllergic rhinitis is an immunoglobulin-E (Ig-E)-mediated response driven by type 2 helper T cells. Hesperidin and thymol are biological agents that possess antioxidant and anti-inflammatory characteristics. The purpose of this study was to investigate the effects of hesperidin and thymol in rats with ovalbumin-induced allergic rhinitis.

methodsThirty adult Sprague-Dawley rats were randomly assigned into five groups, each containing six animals. The first group constituted the negative control group, while the remaining groups were exposed to an ovalbumin-induced model of allergic rhinitis. In the provocation stage, 4 mL/kg saline was administered to the positive control group, 10 mg/kg desloratadine to the reference group, 100 mg/kg hesperidin to the hesperidin group, and 20 mg/kg thymol to the thymol group, all by gastric lavage for 7 days. Nasal symptoms were scored on day 22. Rats were then sacrificed, and intracardiac blood specimens were collected to measure plasma total Ig-E, IL-5, IL-13, total antioxidant capacity (TAC), and total oxidant status (TOS) levels. Nasal tissues were extracted for histopathological and immunochemical examination.

resultsNasal symptom scores were highest in the positive control group, while hesperidin and thymol ameliorated these symptoms to the same extent as desloratadine. Ig-E, IL-5, IL-13, and TOS levels increased, while TAC levels decreased significantly in the allergic rhinitis group compared to the other groups. Significant improvement in these parameters was observed in both the hesperidin and thymol groups. At histopathological and immunohistochemical examination of the nasal cavity, severe allergic inflammation and severe TNF-α expression was determined in rats from the allergic rhinitis group. Mild inflammatory changes and mild TNF-α expression were observed in all three treatment groups.

conclusionBoth hesperidin and thymol were effective in suppressing allergic symptoms and inflammation in the treatment of allergic rhinitis.

Indexed as

AnimalsAnti-Infective AgentsAntioxidantsDisease Models, AnimalHesperidinImmunoglobulin EInflammationInterleukin-13Interleukin-5Nasal CavityOvalbuminOxidantsRats, Sprague-DawleyRhinitis, AllergicThymolTumor Necrosis Factor-alphaAnti-Infective AgentsAntioxidantsHesperidinImmunoglobulin EInterleukin-13Interleukin-5OvalbuminOxidantsThymolTumor Necrosis Factor-alphaAllergic rhinitisHesperidinImmunoglobulin-EOvalbuminThymol

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.